For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Battling COVID-19 with words and images

VIEWPOINT
Marketing specialist Clara McLaurin suggests that in the fight against COVID-19, thoughtful marketing can be as useful as medicine
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1.Field, P, Binet, L (2013) The Long and the Short of it: Balancing the short and long-term effects of marketing. London:IPA
2. Poll: 88% of Kiwis trust Government's coronavirus response, vastly higher than other nations, 1 News, 8 April 2020
3.Covid 19 coronavirus Delta outbreak: NZ Herald-Kantar poll shows what New Zealanders think about elimination strategy NZ Herald 2 September 2021
4. COVID-19: Vaccine data, Ministry of Health
5.Support for mandates drops to 60% in latest 1News Kantar Public Poll, 1 News, 10 March 2022
6.Covid-19 in 12 charts - How boosted is your neighbourhood?, Stuff, 9 February 2022
7. Keith Weed: From 'Trust or Bust' to 'Trsut is a Must', Advertising Assoation website, 14 October 2021